Novo's pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloud
Novo Nordisk’s GLP-1 pill works in kids with diabetes: Type 2 diabetes patients aged 10 to 17 who took Rybelsus for about six months had a statistically significant 0.83% cut in their blood sugar levels ...
April 23, 2026 10:27 AM EDT News Briefing Novo's pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloud ENDPOINTS Novo Nordisk’s GLP-1 pill works in kids with diabetes: Type 2 diabetes patients aged 10 to 17 who took Rybelsus for about six months had … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that